BAKER BROS. ADVISORS LP purchased 4.0% of their position (178.04K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.35M — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2.30K
Price / share
$7.21
Trade value
$16.56K
% of position
Common Stock
Shares
+25.36K
Price / share
$7.21
Trade value
$182.97K
% of position
Common Stock
Shares
+267.00
Price / share
$7.22
Trade value
$1.93K
% of position
Common Stock
Shares
+2.95K
Price / share
$7.22
Trade value
$21.29K
% of position
Common Stock
Shares
+1.06K
Price / share
$7.39
Trade value
$7.83K
% of position
Common Stock
Shares
+11.70K
Price / share
$7.39
Trade value
$86.48K
% of position
Common Stock
Shares
+2.79K
Price / share
$7.54
Trade value
$21.07K
% of position
Common Stock
Shares
+30.88K
Price / share
$7.54
Trade value
$232.81K
% of position
Common Stock
Shares
+7.32K
Price / share
$7.73
Trade value
$56.60K
% of position
Common Stock
Shares
+80.88K
Price / share
$7.73
Trade value
$625.33K
% of position
Common Stock
Shares
+1.04K
Price / share
$7.95
Trade value
$8.27K
% of position
Common Stock
Shares
+11.49K
Price / share
$7.95
Trade value
$91.43K
% of position
Net shares
+178.04K
Net value
$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/10/2025 | P · Purchase | +2.30K | $7.21 | $16.56K | 0.6% | 364.16K | 366.46K |
| Common Stock Indirect | 11/10/2025 | P · Purchase | +25.36K | $7.21 | $182.97K | 0.6% | 4.50M | 4.53M |
| Common Stock Indirect | 11/10/2025 | P · Purchase | +267.00 | $7.22 | $1.93K | 0.1% | 366.46K | 366.72K |
| Common Stock Indirect | 11/10/2025 | P · Purchase | +2.95K | $7.22 | $21.29K | 0.1% | 4.53M | 4.53M |
| Common Stock Indirect | 11/11/2025 | P · Purchase | +1.06K | $7.39 | $7.83K | 0.3% | 366.72K | 367.78K |
| Common Stock Indirect | 11/11/2025 | P · Purchase | +11.70K | $7.39 | $86.48K | 0.3% | 4.53M | 4.54M |
| Common Stock Indirect | 11/11/2025 | P · Purchase | +2.79K | $7.54 | $21.07K | 0.8% | 367.78K | 370.58K |
| Common Stock Indirect | 11/11/2025 | P · Purchase | +30.88K | $7.54 | $232.81K | 0.7% | 4.54M | 4.57M |
| Common Stock Indirect | 11/12/2025 | P · Purchase | +7.32K | $7.73 | $56.60K | 2.0% | 370.58K | 377.90K |
| Common Stock Indirect | 11/12/2025 | P · Purchase | +80.88K | $7.73 | $625.33K | 1.8% | 4.57M | 4.65M |
| Common Stock Indirect | 11/12/2025 | P · Purchase | +1.04K | $7.95 | $8.27K | 0.3% | 377.90K | 378.94K |
| Common Stock Indirect | 11/12/2025 | P · Purchase | +11.49K | $7.95 | $91.43K | 0.2% | 4.65M | 4.66M |
| Total | +178.04K | $1.35M | ||||||